Is there an extra dose in a Wegovy pen?

Why do people think there might be an extra dose?

It is a very common question, and an understandable one. Wegovy pens are pre-filled and self-contained, so it is natural to wonder whether the device holds more than the label suggests. Some people notice that the pen does not appear completely empty after the fourth dose, or they have read online that Ozempic, the diabetes version of semaglutide, reportedly contained surplus medicine. That idea has carried over into conversations about Wegovy.

The short answer is: yes, there is technically more liquid inside than you will ever deliver through the needle. That is not a secret stash. It is an overfill built into every pre-filled pen as a standard pharmaceutical requirement. Regulators and manufacturers require it so that each of the four metered doses you actually inject contains precisely the right amount of medicine, compensating for small amounts that stay in the dead space of the needle or the mechanism itself.

The misconception worth gently letting go of is the idea that this leftover liquid represents a free extra dose that the manufacturer is withholding. It does not. It is residue from the engineering of accurate drug delivery, and it cannot be safely or reliably extracted.

For a clear breakdown of whether Wegovy has an extra dose in any clinically meaningful sense, the answer is no.

What happens to the medicine left in the pen after four doses?

Once you have administered the fourth dose, the pen is spent in the sense that matters: it has delivered four accurately measured injections. Some residual liquid remains in the cartridge. The pen mechanism itself is designed so that after the last dose the device either locks or the plunger can no longer be depressed to deliver a fifth injection in the normal way.

Even if residual medicine could theoretically be drawn out, doing so would carry real risks. Pre-filled injection devices are not designed for aspiration. You would have no reliable way to measure the volume, no certainty it matches your prescribed dose, and a high chance of introducing air or contamination. NHS guidance on semaglutide is clear that you should use each pen as directed and follow the leaflet, not improvise around the device's limits.

Dispose of spent pens safely. If you want more information on what doses of Wegovy are available across the full schedule, that page covers the licensed strengths from starter through to maintenance.

Does the licensed dose schedule affect how many pens you need each month?

Yes, and this is where understanding the pen's design matters practically. Each pen lasts exactly four weeks, one injection per week. A standard monthly supply is one pen. As you move up the titration ladder, the strength changes but the number of pens stays the same until you reach the 7.2 mg dose.

The approved Wegovy schedule in the UK runs from 0.25 mg up through 0.5 mg, 1.0 mg, 1.7 mg and 2.4 mg, with each strength typically held for around four weeks before the prescriber reviews whether a step-up is appropriate. The MHRA approved a higher 7.2 mg maintenance dose, and a dedicated single-dose 7.2 mg pen was approved in April 2026. At that strength, dosing arrangements differ from earlier strengths, which is exactly why clinical review before any change matters.

If you are wondering whether a dose higher than 2.4 mg exists on the licensed schedule, it does, and our prescribers can discuss whether it is appropriate as part of an ongoing review. The cost picture across the full schedule is covered on the Wegovy cost page, where monthly pricing by dose is set out clearly.

Should you ever try to get more doses from a pen?

No. The clinical, practical and safety reasons all point the same way. Your dose is prescribed. Deviating from it, even by a small amount, changes the pharmacological effect in ways you cannot predict and your prescriber has not sanctioned. Semaglutide works through a carefully structured titration because the body needs time to adjust; an uncontrolled additional dose does not fit that logic.

There is also a device integrity point. Pre-filled pens are single-patient use. Attempting to manipulate a spent pen risks needle-stick injury and exposes any remaining liquid to contamination. The Wegovy Summary of Product Characteristics on the eMC and the Patient Information Leaflet both set out clearly how pens should be used and disposed of, and neither describes a fifth dose.

If you feel your treatment plan needs adjusting, or that your current dose is not working as expected, that conversation belongs with your prescriber. At nume, a real clinician reads every repeat request before anything is dispensed, which is the right moment to raise those questions. You can explore how the Wegovy dose ladder works for more context, or visit our treatment page to check your eligibility if you have not yet started.